Federal Awards · Award

SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
75N91023C00028
Contractor
Sub-agency / office
National Institutes of Health
Award amount
$2,049,979
Period of performance
Sep 15, 2023 – Sep 14, 2025
NAICS
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
PSC AN12
Place of performance
WA

Public award description

SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. Click Gemini to copy the research question when your browser allows, or use Copy question.